← Open Payments lookup

KRISTIN BUSSE: Open Payments

NPI 1568821429 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,307 in 108 payments from 19 companies in 2025. Trend: 2023 $1,887 · 2024 $1,488 · 2025 $2,307

Food & beverage: $2,307
CompanyPaymentsAmount
Gilead Sciences, Inc.21$463
ABBVIE INC.24$447
Janssen Biotech, Inc.21$302
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$192
Ipsen Biopharmaceuticals, Inc3$175
Takeda Pharmaceuticals U.S.A., Inc.4$120
Madrigal Pharmaceuticals4$84
Janssen Scientific Affairs, LLC1$83
Ardelyx, Inc.4$80
Celltrion USA Inc.4$72

Products named: TREMFYA, RINVOQ, XIFAXAN, IQIRVO, Epclusa, EOHILIA, LINZESS, REZDIFFRA.

Industry payments across NE — which companies pay providers there.